Related Experiment Video
Updated: Sep 27, 2026

Expression and Purification of Virus-like Particles for Vaccination
Published on: June 2, 2016
Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric
Soile Blomqvist1, Anne-Lise Bruu2, Mirja Stenvik1
1Department of Microbiology, Enterovirus Laboratory, National Public Health Institute (KTL), Mannerheimintie 166, 00300 Helsinki, Finland.
Insights
A rare Sabin 3/Sabin 2/Sabin 3 recombinant poliovirus was found in a child 12 weeks after oral poliovirus vaccine. This chimeric virus likely arose from recombination within the vaccinee, not from circulating vaccine-derived poliovirus.
Area of Science:
- Virology
- Molecular Biology
- Vaccinology
Background:
- Oral poliovirus vaccine (OPV) can undergo recombination, leading to vaccine-derived poliovirus (VDPV).
- Intertypic recombination between different Sabin poliovirus strains is a known phenomenon.
- Understanding the origins and characteristics of recombinant polioviruses is crucial for polio eradication efforts.
Purpose of the Study:
- To characterize an intertypic recombinant poliovirus (Sabin 3/Sabin 2/Sabin 3) isolated from a vaccine recipient.
- To investigate the genetic and antigenic properties of the recombinant poliovirus.
- To determine the likely origin of the recombinant virus (in vivo recombination vs. circulating VDPV).
Main Methods:
- Isolation and sequencing of the recombinant poliovirus from a fecal specimen.
- Detailed genomic analysis to identify recombination sites and nucleotide/amino acid substitutions.
- Comparison of the recombinant genome with parental Sabin strains.
- Assessment of antigenic properties and neutralizing antibody responses.
Main Results:
- An intertypic Sabin 3/Sabin 2/Sabin 3 recombinant poliovirus was identified 12 weeks post-OPV administration.
- Recombination occurred in the VP1 capsid protein and RNA polymerase regions, introducing Sabin 2-derived amino acids into the Sabin 3 capsid.
- The recombinant virus showed 33 nucleotide differences from parental strains, including amino acid substitutions in capsid and non-structural proteins, affecting antigenic sites.
- Despite genetic changes, the recombinant did not exhibit type 2-specific antigenic features, and neutralizing antibody titers against it were comparable to Sabin 3.
Conclusions:
- The isolated chimeric poliovirus was most likely generated by recombination events within the vaccinee.
- This finding highlights the potential for in vivo genetic reassortment of poliovirus strains following OPV administration.
- The study underscores the importance of continued surveillance for poliovirus genetic diversity during polio eradication.
Abstract:
A Sabin 3/Sabin 2/Sabin 3 (S3/2/3) intertypic recombinant poliovirus was isolated from a faecal specimen from a 2-year-old healthy boy approximately 12 weeks after administration of oral poliovirus vaccine. The first recombination junction was in the genomic region encoding the VP1 capsid protein between nucleotide positions 3274 and 3285 (numbering according to Sabin 3) and the second was in the RNA polymerase region (nucleotide positions 6824 and 6825). The recombination had introduced six Sabin 2-derived amino acids into the Sabin 3 capsid environment in the carboxyl terminus of VP1. The complete genome of the recombinant virus differed from corresponding parental Sabin strains at 33 nucleotide positions, nine of them resulting in an amino acid substitution. Four substitutions were in the capsid proteins and five were in the region encoding the non-structural proteins. One amino acid was changed in the antigenic site 2B and two in site 3B. In addition, the whole antigenic site 3A was replaced by Sabin 2-specific amino acids, but the antigenic characteristics of the S3/2/3 did not show type 2-specific features. Neutralizing antibody titres in sera from Finnish children immunized with the inactivated poliovirus vaccine were not lower against the recombinant virus than against Sabin 3. Our results suggest that the chimeric virus was most likely generated by recombination events in the vaccinee, rather than representing progeny of circulating vaccine-derived virus.
Related Concept Videos
Poliomyelitis
Leaky Scanning

